He is always constantly evaluating his options. To
Post# of 30028
Posted On: 02/19/2015 11:09:25 PM
Re: Anaconda83 #16966
Quote:That's exactly what GC did at the Noble Financial Investor's Conference held on Jan. 19, 2015. Check out the audio clip of Gerald's comments about the diagnostics spin-off.
He is always constantly evaluating his options. To be honest, I think the people in this forum are evaluating his options more often than he is. I really believe he already knows how he wants to handle it, he is just trying to figure out a way to squeeze the most value out of the play. (Which is fine.) Just don't get everyone salivating with all sorts of possible scenarios and then clam up, when in fact, he is probably just trying to exploit one opportunity to the fullest (one again, which is fine.) Best way to handle it is to tell shareholders, "We are currently evaluating our options with Dx for greatest value." Instead, he dances around and now everyone is worried about an IPO, spinoff, sale, partnership, etc, etc. Uncertainty is so dog gone hard to place a valuation on.
SpinOff
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼